Abstract
Purpose. The present investigation was done to study the intestinal absorption of three oxytocin peptide analogues and to elucidate the role of pancreatic juice on their absorption.
Methods. In conscious chronically catheterized pigs (6–8 weeks of age) plasma concentration of the peptides, [Mpa1, D-Tyr(Ethyl)2, Thr4, Orn8]-oxytocin (F314), [Mpa1, D-Tyr(Ethyl)2, Val4, D-Arg8]-oxytocin (CAT), and [Mpa1, D-Tyr(Ethyl)2, Thr4, Orn8, desGly9, carba6]-oxytocin (F327) after intraduodenal administration, during presence or diversion of the pancreatic juice via a pancreatic duct catheter, were determined by radioimmunoassay. The stability of the peptides to degradation was determined in vitro by incubation with activated pancreatic juice, chymotrypsin or trypsin, followed by reversed phase HPLC analyses.
Results. All peptides were absorbed with a bioavailability of about 0.5% in the presence of pancreatic juice, but increased to 1.0%, 2.1%, and 13.5% for F314, CAT, and F327, respectively, when the pancreatic juice was diverted from the intestine. After incubation with pancreatic juice 95% of F314, 98% of F327, and 100% of CAT was found intact. When incubated with trypsin CAT remained intact while F314 and F327 were degraded by 54% and 46%, respectively. Incubation with purified chymotrypsin did not degrade the test peptides.
Conclusions. The results indicate that the increased absorption of peptides observed under conditions of diverted pancreatic juice cannot only be explained by the absence of pancreatic enzymes, but also by changed absorptive properties in the gastrointestinal tract.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Y.-J. Fei, Y. Kanai, S. Nussberger, V. Ganapathy, F. H. Leibach, M. F. Romero, S. K. Singh, W. F. Boron, and M. A. Hediger. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 369:563–566 (1994).
J. R. Pappenheimer. On the coupling of membrane digestion with intestinal absorption of sugars and amino acids. Am. J. Physiol. 265:G409–G417 (1993).
K. Atisook and J. L. Madara. An oligopeptide permeates intestinal tight junctions at glucose-elicited dilatations. Implications for oligopeptide absorption. Gastroenterology 100:719–724 (1991).
M. L. G. Gardner. Absorption of intact proteins and peptides. In L. R. Johnson (ed.), Physiology of the gastrointestinal tract. Volume 2. 3rd ed. New York, 1994, pp. 1795–1820.
C. M. Ryan, J. Schmidt, K. Lewandrowski, C. C. Compton, D. W. Rattner, A. L. Warshaw, R. G. Tompkins. Gut macromolecular Permeability in pancreatitis correlates with severity of disease in rats. Gastroenterol. 104:890–895 (1993).
H. Vilhardt and P. Bie. Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues. Eur. J. Pharmacol. 93:201–204 (1983).
S. Lundin and H. Vilhardt. Absorption of intragastrically administered dDAVP vasopressin in conscious dogs. Life Sci. 38:703–709 (1986).
K. T. Matsui, K. Kimura, K. Orta, K. Iitake, M. Shoji, M. Inoue, and K. Yoshinaga. Resistance of 1 desamino-8-D-arginine vasopressin to in vitro degradation as compared with arginine vasopressin. Endocrinol. Jpn. 32:547–558 (1985).
P. Melin, J. Trojnar, B. Johansson, H. Vilhardt, and M. Åkerlund. Synthetic antagonist of the myometrial response to vasopressin and oxytocin. J. Endocrinol. 111:125–131 (1986).
S. G. Pierzynowski, B. R. Weström, B. W. Karlsson, J. Svendsen, and B. Nilsson. Pancreatic cannulation of young pigs for long-term study of exocrine pancreatic function. Can. J. Anim. Sci. 68:953–959 (1988).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275 (1951).
S. G. Pierzynowski, B. R. Weström, J. Svendsen, and B. W. Karlsson. Development of exocrine pancreas function in chronically cannulated pigs during 1–13 weeks of postnatal life. J. Pediatr. Gastroenterol. Nutr. 10:206–212 (1990).
S. Lundin, S. G. Pierzynowski, B. R. Weström, and H.-I. Bengtsson. Biliary excretion of the vasopressin analogue dDAVP after intraduodenal, intrajugular, and intraportal administration in the conscious pig. Pharmacol. Toxicol. 68:177–180 (1991).
S. Lundin, H. G. Folkesson, S. G. Pierzynowski, and H.-I. Bengtsson. Gastrointestinal absorption and plasma clearance rates of [D-Arg8] vasopressin analogues in the rat. Peptides 15:809–814 (1994).
R. D. Brown and J. E. Manno. ESTRIP, a basic computer programme for obtaining initial polyexponential parameter estimates. J. Pharm. Sci. 67:1687–1691 (1978).
M. S. Karls, B. D. Rush, K. F. Wilkinson, T. J. Vidmar, P. S. Burton, and M. J. Ruwart. Desolvation energy: A major determinant of absorption, but not clearance, of peptides in rats. Pharm. Res. 8:1477–1481 (1991).
T. Janáky, F. A. László, F. Sirokmán, and J.-L. Morgat. Biological half-life and organ distribution of [3H]8-arginine-vasopressin in the rat. J. Endocrinol. 93:295–303 (1982).
D. J. Ahnen. Protein digestion and assimilation. In T. Yamada (ed.), Textbook of gastroenterology, JB Lippincott, Philadelphia, 1991, pp. 381–392.
A. Fjellestad-Paulsen, C. Söderberg-Ahlm, and S. Lundin. Metabolism of vasopressin, oxytocin, and their analogues by juice and brush border membranes form the human gastrointestinal tract. Peptides (In press).
B. O. Schneeman, I. Chang, L. B. Smith, and R. L. Lyman. Effect of dietary amino acids, casein, and soybean trypsin inhibitor on pancreatic protein secretion in rats. J. Nutr. 107:281–288 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lundin, P.D.P., Lundin, S., Olsson, H. et al. Enhanced Intestinal Absorption of Oxytocin Peptide Analogues in the Absence of Pancreatic Juice in Pigs. Pharm Res 12, 1478–1482 (1995). https://doi.org/10.1023/A:1016283320527
Issue Date:
DOI: https://doi.org/10.1023/A:1016283320527